NF105: A Phase II Study of Cabozantinib (XL 184) for Plexiform Neurofibromas in Subjects with Neurofibromatosis Type 1 in children and adults

Project: Research project

Project Details

StatusActive
Effective start/end date10/8/1810/7/21

Funding

  • University of Alabama at Birmingham
  • University of Alabama at Birmingham